Mounjaro 15mg/0.5ml is the highest available dose for weekly blood sugar control in adults with type 2 diabetes. It contains tirzepatide, a dual-action agent that enhances insulin secretion and lowers glucose levels by targeting GIP and GLP-1 receptors. This advanced dose is often used in later stages of therapy or for patients needing stronger support. Each box includes a single pre-filled pen for easy subcutaneous injection. Use only under strict medical supervision.